Indivior Pharmaceuticals Inc
Indivior Pharmaceuticals Inc is a holding company, which engages in the development, manufacture and sale of buprenorphine-based prescription drugs for treatment of opioid dependence. Its products include Suboxone Film, Suboxone Tablet, and Subutex Tablet. It operates through the following geographical segments: United States, Rest of World, and United Kingdom. The company was founded on September 26, 2014 and is headquartered in North Chesterfield, VA.
| Period | EPS | Revenue | FCF |
|---|---|---|---|
| 2026 Q1 | 0.71 | $317M | -$29M |
| 2025 Q4 | 0.82 | $358M | -$245M |
| 2025 Q3 | 0.34 | $314M | -$59M |
| 2025 Q2 | 0.14 | $302M | $148M |
| 2025 Q1 | 0.38 | $266M | $70M |
| 2024 Q4 | 0.45 | $299M | -$21M |
| 2024 Q3 |
| 0.03 |
| $307M |
| -$1M |
| 2024 Q2 | -0.72 | $299M | $84M |